Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2002-12-4
pubmed:abstractText
We report on 2 patients with idiopathic Parkinson's disease who experienced marked improvement in symptoms following the addition of itraconazole to current cabergoline treatment. Plasma levels of cabergoline were analyzed in one of the patients and increased to approximately 300% during treatment with itraconazole, which paralleled major clinical improvement.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0885-3185
pubmed:author
pubmed:copyrightInfo
Copyright 2002 Movement Disorder Society
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1360-2
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:12465083-Adult, pubmed-meshheading:12465083-Aged, pubmed-meshheading:12465083-Antifungal Agents, pubmed-meshheading:12465083-Antiparkinson Agents, pubmed-meshheading:12465083-Cytochrome P-450 CYP3A, pubmed-meshheading:12465083-Cytochrome P-450 Enzyme System, pubmed-meshheading:12465083-Dose-Response Relationship, Drug, pubmed-meshheading:12465083-Drug Interactions, pubmed-meshheading:12465083-Drug Therapy, Combination, pubmed-meshheading:12465083-Ergolines, pubmed-meshheading:12465083-Female, pubmed-meshheading:12465083-Humans, pubmed-meshheading:12465083-Itraconazole, pubmed-meshheading:12465083-Male, pubmed-meshheading:12465083-Neurologic Examination, pubmed-meshheading:12465083-Onychomycosis, pubmed-meshheading:12465083-Parkinson Disease, pubmed-meshheading:12465083-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Cabergoline plasma concentration is increased during concomitant treatment with itraconazole.
pubmed:affiliation
Centre for Clinical Pharmacology, University of Aarhus, Aarhus, Denmark. Jakob@farm.au.dk
pubmed:publicationType
Journal Article, Case Reports